Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism

Theacrine promotes acylcarnitine metabolism in NAFLD through the SIRT3/LCAD signaling pathway. The target of theacrine's activities on NAFLD is identified as SIRT3.